Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @POSTECTRIMS
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @POSTECTRIMS
-
Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis. https://buff.ly/36WsRvL
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/lg0nIEUN1a
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis. https://buff.ly/2RT1ApA
#MultipleSclerosis#PatientSafety#healthcare#treatment#msHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Response to oxidative stress of peripheral blood mononuclear cells from multiple sclerosis patients and healthy controls. https://buff.ly/2uX8IIE
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/heP9a2csaO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis. https://buff.ly/2GOASIr
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/rHdUs4rMLV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neurodegeneration in multiple sclerosis and neuromyelitis optica. https://buff.ly/2GCV1U6
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/xSRPDzvYXH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
B cells in multiple sclerosis. https://buff.ly/2DK6hI0
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/hkvkEevAGI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Evaluation of The Expression Levels of Three Long Non-Coding RNAs in Multiple Sclerosis. https://buff.ly/2vFJa2R
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/7yZU42Uy04
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression. https://buff.ly/37Tag4X
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/3IlPuXOv6p
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A Potential Life-Threatening Reaction to Glatiramer Acetate in Rett Syndrome. https://buff.ly/2RIMfI7
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/rUYdUC1dn8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)2D, but No Difference in Ratio of 25(OH)D/24,25(OH)2D and FGF23 Concentrations. https://buff.ly/36HIGpX
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/uhlDLK3HBe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Resolution of inflammation during multiple sclerosis. https://buff.ly/2UbW9DN
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/LUWovV43xJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Intrathecal Injection of Peripherally Mobilized Blood Stem Cells to Treat Multiple Sclerosis. https://buff.ly/2FtPquS
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/cZDoR0G3xf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Functional and structural changes in the visual pathway in multiple sclerosis. https://buff.ly/38Nn8tt
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/CaHyh7FbRJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Determinants of quality of life in pediatric- and adult-onset multiple sclerosis. https://buff.ly/3aVQdov
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/knVq87TWDx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Functional and structural changes in the visual pathway in multiple sclerosis. https://buff.ly/38Nn8tt
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/s11YghovR1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. https://buff.ly/2lScGKJ
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/PAEynSL64D
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Os recordamos que la XIII edición de
#postECTRIMS se celebrará los días 2 y 3 de Octubre en Madrid.#SaveTheDate#TheClockIsTicking#MSpic.twitter.com/dLfRgW2JwF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Serum and saliva total tau protein as a marker for relapsing-remitting multiple sclerosis. https://buff.ly/2O7jEKk
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/kIyfMsu2qi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis. https://buff.ly/2uGpGef
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/iTSXwYW5ll
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis. https://buff.ly/2vu0aZS
#MultipleSclerosis#PatientSafety#healthcare#treatment#mspic.twitter.com/CTOnxFzyTd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.